CVS Health (NYSE:CVS) disclosed its fourth-quarter financial results and revised its earnings forecast for 2024 downwards.

In the fourth quarter of 2023, CVS Health announced an earnings per share (EPS) of $2.12, surpassing the analysts’ consensus of $1.98. The company’s revenue for the quarter was $93.81 billion, exceeding expectations of $90.25 billion.

Revenue from health services reached $49.15 billion, outperforming the anticipated $45.96 billion by analysts.

Looking into the full fiscal year of 2024, CVS Health adjusted its EPS forecast to a minimum of $8.30, a decrease from the previously projected $8.50. This adjustment comes in below the analyst consensus of $8.47.

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

× ¿Cómo puedo ayudarte?